June 01, 2020
Bayer HealthCare urged a California federal court against allowing a generic pet medication maker to flout international protocol for how to serve documents in a $114 million antitrust case, saying the company is trying to use the COVID-19 pandemic as a scapegoat for its own delays and errors.
May 18, 2020
A California federal court has been urged to allow German-based Bayer AG and a subsidiary to be served documents for an antitrust suit over medication for fleas and ticks via email and through U.S.-based Bayer HealthCare LLC's attorneys at Arnold & Porter, due to service hiccups caused by the coronavirus pandemic.
April 06, 2020
Bayer HealthCare has urged a California federal judge to jettison a competitor's antitrust suit, saying the action can't prove Bayer unlawfully dominated sales of a topical flea and tick medication through exclusivity deals, because the arrangements don't lock rivals out of the market.